Information for "Osimertinib for EGFRmutant united states using central nervous system metastases a new metaanalysis along with methodical review"
From EECH Central
Basic information
Display title | Osimertinib for EGFRmutant united states using central nervous system metastases a new metaanalysis along with methodical review |
Default sort key | Osimertinib for EGFRmutant united states using central nervous system metastases a new metaanalysis along with methodical review |
Page length (in bytes) | 3,819 |
Page ID | 1421712 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Datecancer1 (Talk | contribs) |
Date of page creation | 08:23, 30 April 2024 |
Latest editor | Datecancer1 (Talk | contribs) |
Date of latest edit | 08:23, 30 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |